289 related articles for article (PubMed ID: 8341688)
1. Suppression of oncogenic Ras by mutant neurofibromatosis type 1 genes with single amino acid substitutions.
Nakafuku M; Nagamine M; Ohtoshi A; Tanaka K; Toh-e A; Kaziro Y
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6706-10. PubMed ID: 8341688
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Ras/Raf interaction by anti-oncogenic mutants of neurofibromin, the neurofibromatosis type 1 (NF1) gene product, in cell-free systems.
Mori S; Satoh T; Koide H; Nakafuku M; Villafranca E; Kaziro Y
J Biol Chem; 1995 Dec; 270(48):28834-8. PubMed ID: 7499408
[TBL] [Abstract][Full Text] [Related]
3. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae.
Xu GF; Lin B; Tanaka K; Dunn D; Wood D; Gesteland R; White R; Weiss R; Tamanoi F
Cell; 1990 Nov; 63(4):835-41. PubMed ID: 2121369
[TBL] [Abstract][Full Text] [Related]
4. The GTPase-activating NF1 fragment of 91 amino acids reverses v-Ha-Ras-induced malignant phenotype.
Nur-E-Kamal MS; Varga M; Maruta H
J Biol Chem; 1993 Oct; 268(30):22331-7. PubMed ID: 8226742
[TBL] [Abstract][Full Text] [Related]
5. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins.
Ballester R; Marchuk D; Boguski M; Saulino A; Letcher R; Wigler M; Collins F
Cell; 1990 Nov; 63(4):851-9. PubMed ID: 2121371
[TBL] [Abstract][Full Text] [Related]
6. A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity.
Andersen LB; Ballester R; Marchuk DA; Chang E; Gutmann DH; Saulino AM; Camonis J; Wigler M; Collins FS
Mol Cell Biol; 1993 Jan; 13(1):487-95. PubMed ID: 8417346
[TBL] [Abstract][Full Text] [Related]
7. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21.
Martin GA; Viskochil D; Bollag G; McCabe PC; Crosier WJ; Haubruck H; Conroy L; Clark R; O'Connell P; Cawthon RM
Cell; 1990 Nov; 63(4):843-9. PubMed ID: 2121370
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Ras effector mutant interactions with the NF1-GAP related domain.
Marshall MS; Hettich LA
Oncogene; 1993 Feb; 8(2):425-31. PubMed ID: 8426748
[TBL] [Abstract][Full Text] [Related]
9. Identification of neurofibromin mutants that exhibit allele specificity or increased Ras affinity resulting in suppression of activated ras alleles.
Morcos P; Thapar N; Tusneem N; Stacey D; Tamanoi F
Mol Cell Biol; 1996 May; 16(5):2496-503. PubMed ID: 8628317
[TBL] [Abstract][Full Text] [Related]
10. Functional significance of lysine 1423 of neurofibromin and characterization of a second site suppressor which rescues mutations at this residue and suppresses RAS2Val-19-activated phenotypes.
Poullet P; Lin B; Esson K; Tamanoi F
Mol Cell Biol; 1994 Jan; 14(1):815-21. PubMed ID: 8264648
[TBL] [Abstract][Full Text] [Related]
11. IRA2, a second gene of Saccharomyces cerevisiae that encodes a protein with a domain homologous to mammalian ras GTPase-activating protein.
Tanaka K; Nakafuku M; Tamanoi F; Kaziro Y; Matsumoto K; Toh-e A
Mol Cell Biol; 1990 Aug; 10(8):4303-13. PubMed ID: 2164637
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Saccharomyces cerevisiae strains expressing ira1 mutant alleles modeled after disease-causing mutations in NF1.
Gil R; Seeling JM
Mol Cell Biochem; 1999 Dec; 202(1-2):109-18. PubMed ID: 10706001
[TBL] [Abstract][Full Text] [Related]
13. Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells.
Hiatt KK; Ingram DA; Zhang Y; Bollag G; Clapp DW
J Biol Chem; 2001 Mar; 276(10):7240-5. PubMed ID: 11080503
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation.
Nishi T; Lee PS; Oka K; Levin VA; Tanase S; Morino Y; Saya H
Oncogene; 1991 Sep; 6(9):1555-9. PubMed ID: 1923522
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of the neurofibromatosis type 1 protein product.
DeClue JE; Cohen BD; Lowy DR
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):9914-8. PubMed ID: 1946460
[TBL] [Abstract][Full Text] [Related]
16. Novel, activated RAS mutations alter protein-protein interactions.
Dalley BK; Cannon JF
Oncogene; 1996 Sep; 13(6):1209-20. PubMed ID: 8808695
[TBL] [Abstract][Full Text] [Related]
17. GapIII, a new brain-enriched member of the GTPase-activating protein family.
Baba H; Fuss B; Urano J; Poullet P; Watson JB; Tamanoi F; Macklin WB
J Neurosci Res; 1995 Aug; 41(6):846-58. PubMed ID: 7500386
[TBL] [Abstract][Full Text] [Related]
18. S. cerevisiae genes IRA1 and IRA2 encode proteins that may be functionally equivalent to mammalian ras GTPase activating protein.
Tanaka K; Nakafuku M; Satoh T; Marshall MS; Gibbs JB; Matsumoto K; Kaziro Y; Toh-e A
Cell; 1990 Mar; 60(5):803-7. PubMed ID: 2178777
[TBL] [Abstract][Full Text] [Related]
19. Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function.
Johnson MR; DeClue JE; Felzmann S; Vass WC; Xu G; White R; Lowy DR
Mol Cell Biol; 1994 Jan; 14(1):641-5. PubMed ID: 8264632
[TBL] [Abstract][Full Text] [Related]
20. Somatic mutations in the neurofibromatosis 1 gene in human tumors.
Li Y; Bollag G; Clark R; Stevens J; Conroy L; Fults D; Ward K; Friedman E; Samowitz W; Robertson M
Cell; 1992 Apr; 69(2):275-81. PubMed ID: 1568247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
